SARS-CoV-2 Eris variant spreads faster and dodges immunity

Study investigates the characteristics of the EG.5.1 “Eris” variant of SARS-CoV-2, finding it more transmissible among hamsters and slightly better at evading immunity compared to the XBB.1.5 variant. The results suggest that these properties could be driving the variant’s increasing prevalence in human populations.

AstraZeneca halts two PhIII hyperkalemia studies intended to spotlight Lokelma’s clinical value

AstraZeneca announced early Friday morning that it is stopping work on two late-stage trials designed to gather value-added evidence for Lokelma in hyperkalemia, a chronic

December 2, 2023

Robert F. Kennedy is pitching centrism on health care, even on abortion

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays. What RFK’s new lane means

October 10, 2023

Cansortium Completes RIV Capital Acquisition

FLUENT Completes Acquisition of RIV Capital, Adding New York Retail, Wholesale and Cultivation Operations to its Multi-State Footprint Accelerates FLUENT’s entry into one of the

December 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.